Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ganoderma lucidum diabetes:

Search results

Items: 1 to 20 of 55

1.

A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway.

Yang Z, Wu F, He Y, Zhang Q, Zhang Y, Zhou G, Yang H, Zhou P.

Food Funct. 2017 Dec 7. doi: 10.1039/c7fo01489a. [Epub ahead of print]

PMID:
29215104
2.

Enzymatic System of Antioxidant Protection of Erythrocytes in Diabetic Rats Treated with Medicinal Mushrooms Agaricus brasiliensis and Ganoderma lucidum (Agaricomycetes).

Vitak TY, Wasser SP, Nevo E, Sybirna NO.

Int J Med Mushrooms. 2017;19(8):697-708. doi: 10.1615/IntJMedMushrooms.2017021305.

PMID:
29199569
3.

Natural Health Products and Diabetes: A Practical Review.

Necyk C, Zubach-Cassano L.

Can J Diabetes. 2017 Dec;41(6):642-647. doi: 10.1016/j.jcjd.2017.06.014. Epub 2017 Aug 18. Review.

PMID:
28826695
4.

Effect of medicinal mushrooms on blood cells under conditions of diabetes mellitus.

Vitak T, Yurkiv B, Wasser S, Nevo E, Sybirna N.

World J Diabetes. 2017 May 15;8(5):187-201. doi: 10.4239/wjd.v8.i5.187. Review.

5.

The solid-state fermentation of Artemisia capillaris leaves with Ganoderma lucidum enhances the anti-inflammatory effects in a model of atopic dermatitis.

Son HU, Lee S, Heo JC, Lee SH.

Int J Mol Med. 2017 May;39(5):1233-1241. doi: 10.3892/ijmm.2017.2945. Epub 2017 Apr 7.

6.

Antidiabetic activity of Ganoderma lucidum polysaccharides F31 down-regulated hepatic glucose regulatory enzymes in diabetic mice.

Xiao C, Wu Q, Zhang J, Xie Y, Cai W, Tan J.

J Ethnopharmacol. 2017 Jan 20;196:47-57. doi: 10.1016/j.jep.2016.11.044. Epub 2016 Nov 27.

PMID:
27902927
7.

Ganoderic Acid A Targeting β-Catenin in Wnt Signaling Pathway: In Silico and In Vitro Study.

Gill BS, Kumar S, Navgeet.

Interdiscip Sci. 2016 Aug 22. [Epub ahead of print]

PMID:
27549815
8.

A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome.

Klupp NL, Kiat H, Bensoussan A, Steiner GZ, Chang DH.

Sci Rep. 2016 Aug 11;6:29540. doi: 10.1038/srep29540.

9.

Three kinds of Ganoderma lucidum polysaccharides attenuate DDC-induced chronic pancreatitis in mice.

Li K, Yu M, Hu Y, Ren G, Zang T, Xu X, Qu J.

Chem Biol Interact. 2016 Mar 5;247:30-8. doi: 10.1016/j.cbi.2016.01.013. Epub 2016 Jan 27.

PMID:
26826268
10.

Structural Changes of Erythrocyte Surface Glycoconjugates after Treatment with Medicinal Mushrooms.

Vitak TY, Wasser SP, Nevo E, Sybirna NO.

Int J Med Mushrooms. 2015;17(9):867-78.

PMID:
26756299
11.
12.

Tetracyclic triterpenoids in herbal medicines and their activities in diabetes and its complications.

Hamid K, Alqahtani A, Kim MS, Cho JL, Cui PH, Li CG, Groundwater PW, Li GQ.

Curr Top Med Chem. 2015;15(23):2406-30. Review.

PMID:
26088353
13.

Effect of Ganoderma lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats.

Wang F, Zhou Z, Ren X, Wang Y, Yang R, Luo J, Strappe P.

Lipids Health Dis. 2015 May 22;14:49. doi: 10.1186/s12944-015-0045-y.

16.

Chronic Treatment with a Water-Soluble Extract from the Culture Medium of Ganoderma lucidum Mycelia Prevents Apoptosis and Necroptosis in Hypoxia/Ischemia-Induced Injury of Type 2 Diabetic Mouse Brain.

Xuan M, Okazaki M, Iwata N, Asano S, Kamiuchi S, Matsuzaki H, Sakamoto T, Miyano Y, Iizuka H, Hibino Y.

Evid Based Complement Alternat Med. 2015;2015:865986. doi: 10.1155/2015/865986. Epub 2015 Apr 6.

17.

Anti-diabetic effects of Ganoderma lucidum.

Ma HT, Hsieh JF, Chen ST.

Phytochemistry. 2015 Jun;114:109-13. doi: 10.1016/j.phytochem.2015.02.017. Epub 2015 Mar 16.

PMID:
25790910
18.
19.

Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors.

Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A.

Cochrane Database Syst Rev. 2015 Feb 17;(2):CD007259. doi: 10.1002/14651858.CD007259.pub2. Review.

PMID:
25686270
20.

Isolation and characterization of a hyperbranched proteoglycan from Ganoderma lucidum for anti-diabetes.

Pan D, Wang L, Chen C, Hu B, Zhou P.

Carbohydr Polym. 2015 Mar 6;117:106-14. doi: 10.1016/j.carbpol.2014.09.051. Epub 2014 Sep 28.

PMID:
25498615

Supplemental Content

Loading ...
Support Center